Dachaigh › Luchd-obrach › A & Z Pharmaceutical, Inc.
A & Z Pharmaceutical, Inc.: Tuarastalan H-1B agus taic bhìosa
Chuir A & Z Pharmaceutical, Inc. 8 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 7. Tuarastal meadhanach a chaidh a thabhann: $118,000.
A bheil A & Z Pharmaceutical, Inc. a’ toirt taic do bhìosaichean H-1B?
Chuir A & Z Pharmaceutical, Inc. 8 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 13 Gibl 2026. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Senior Director, Quality Assurance | 2 | $125,000 |
| Senior Manager, R&D | 2 | $120,000 |
| Process Engineer | 1 | $100,000 |
| Planning and Logistics Associate | 1 | $50,856 |
| Senior Manager Research & Development/ Principal Scientist | 1 | $118,000 |
| Formulation Scientist (R&D) | 1 | $65,000 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 1 | $130,000 |
| FY2024 | 2 | $120,000 |
| FY2025 | 4 | $109,000 |
| FY2026 | 1 | $65,000 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Chemists3
- Microbiologists2
- Software Developers1
- Statistical Assistants1
- Medical Scientists, Except Epidemiologists1
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Formulation Scientist (R&D) | $65,000–$85,000 Ìre I | Hauppauge, NY | 13 Gibl 2026 | 15 Gibl 2026 | Dearbhaichte |
| Senior Director, Quality Assurance | $120,000–$170,000 Ìre IV | Hauppauge, NY | 4 Sult 2025 | 17 Faoi 2026 | Dearbhaichte |
| Process Engineer | $100,000–$130,000 Ìre I | Hauppauge, NY | 12 Ògmh 2025 | 30 Sult 2025 | Dearbhaichte |
| Planning and Logistics Associate | $50,856–$70,000 Ìre I | Hauppauge, NY | 15 Gibl 2025 | 1 Dàmh 2025 | Dearbhaichte |
| Senior Manager Research & Development/ Principal Scientist | $118,000–$140,000 Ìre III | Hauppauge, NY | 9 Gibl 2025 | 10 Gibl 2025 | Dearbhaichte |
| Senior Manager, R&D | $120,000–$140,000 Ìre IV | Hauppauge, NY | 16 Samh 2023 | 28 Samh 2023 | Dearbhaichte |
| Senior Manager, R&D | — Ìre IV | Hauppauge, NY | 14 Samh 2023 | 28 Samh 2023 | Diùltadh |
| Senior Director, Quality Assurance | $130,000–$165,000 Ìre IV | Hauppauge, NY | 28 Dùbh 2022 | 9 Faoi 2023 | Dearbhaichte |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).